Project Number EUJPND-European Commission-EC Grant-1025 Agency/Funding Organization European Commission Funding Year 2016 View Full Project Details for Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients Research Categorization Primary Disease / Condition Multiple Dementias CADRO Category H. Brain Aging and Common Mechanisms related to Dementia 2. Common Mechanisms Related to Dementias c. Clinical Research and Epidemiology Researcher and Organization Principal Investigator EC Grant Principal Investigator First Name EC Grant Principal Investigator Last Name EC Grant Awardee Organization EC Grant Contact PI Country Multi-national Project Detail Funding Opportunity Announcement European Commission Horizon 2020 FY Overall Cost $1,495,109 Funding Organization Agency/Funding Organization European Commission Funding Organization Country Multi-national Special Initiative EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)
